Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Amortization of Deferred Charges: 2009-2025

Historic Amortization of Deferred Charges for Prestige Consumer Healthcare (PBH) over the last 16 years, with Sep 2025 value amounting to $447,000.

  • Prestige Consumer Healthcare's Amortization of Deferred Charges rose 4.44% to $447,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 million, marking a year-over-year decrease of 53.90%. This contributed to the annual value of $1.8 million for FY2025, which is 66.53% down from last year.
  • As of Q3 2025, Prestige Consumer Healthcare's Amortization of Deferred Charges stood at $447,000, which was up 1.13% from $442,000 recorded in Q2 2025.
  • Prestige Consumer Healthcare's Amortization of Deferred Charges' 5-year high stood at $1.8 million during Q1 2023, with a 5-year trough of $428,000 in Q3 2024.
  • Moreover, its 3-year median value for Amortization of Deferred Charges was $454,000 (2024), whereas its average is $875,818.
  • Its Amortization of Deferred Charges has fluctuated over the past 5 years, first skyrocketed by 111.37% in 2021, then slumped by 71.07% in 2025.
  • Over the past 5 years, Prestige Consumer Healthcare's Amortization of Deferred Charges (Quarterly) stood at $1.4 million in 2021, then crashed by 40.77% to $815,000 in 2022, then spiked by 74.72% to $1.4 million in 2023, then plummeted by 69.52% to $434,000 in 2024, then increased by 4.44% to $447,000 in 2025.
  • Its Amortization of Deferred Charges was $447,000 in Q3 2025, compared to $442,000 in Q2 2025 and $438,000 in Q1 2025.